Shares of Ardent Health Partners (ARDT) surged 6.00% in after-hours trading on Tuesday following the release of the company's impressive first-quarter 2025 financial results. The healthcare provider reported earnings per share of $0.29, significantly beating the analyst consensus estimate of $0.20 by 45%.
Ardent Health's total revenue for Q1 2025 reached $1.50 billion, marking a 4.0% increase compared to the same period last year. The company's net income attributable to Ardent Health soared by 52% to $41 million, up from $27 million in Q1 2024. Adjusted EBITDA also saw a 2.5% year-over-year increase, reaching $98 million.
Adding to investor optimism, Ardent Health reaffirmed its full-year 2025 financial guidance, projecting total revenue between $6.2 billion and $6.45 billion and adjusted EBITDA in the range of $575 million to $615 million. The company's strong performance was driven by a 7.6% growth in admissions and successful cost management initiatives, including a reduction in supply costs and moderation of professional fee expenses growth.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.